Credit line

Eevia Health Plc secured an SEK 8 million line of credit for working capital purposes to fund continued growth

Eevia Health Plc(“Eevia” or “The Company”), has entered into an agreement whereby Excellity AB, Sweden will provide a line of credit for Eevia up to 8 million Swedish crownsgiving the Company greater working capital flexibility to fund its continued growth.

The duration of the credit is until December 31, 2022. It is not secure. Interest is charged at one point five (1.5)% per month and an arrangement fee of five (5)%.

Stein Ulvethe managing director says:Eevia saw significant improvements in production efficiency in the second quarter of this year. We are now in a strong operational position and will increase our external focus on customer acquisition and profitable sales growth. The line of credit provides short-term working capital to continue our strategic focus on expanding the business.

This disclosure contains information that EEVIA HEALTH PLC is required to make public under the EU Market Abuse Regulation (EU 596/2014). The information has been submitted for publication, through the contact person, the June 24, 2022.

For more information, please contact:

Stein UlveCEO, Eevia Health Plc Gabriella BeniCFO, Eevia Health Plc

E-mail: [email protected] [email protected]

Telephone: +358 400 22 5967 +358 407 48 8666


Eevia Health Plcfounded in March 2017, addresses important health issues with bioactive compounds extracted from plant materials. Materials are mostly wild harvested from primeval Finnish and Swedish forests near or above the polar Circle. Extracts are sold B2B as ingredients in dietary supplements and food brands worldwide. These global brands use the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% certified organic plant extracts. Although one important product, elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, bilberry, chaga and pine bark, are sustainably harvested from the wild.

Eevia Health operates a modern green chemistry production plant in Finland. Manufacturing natural ingredients close to raw material harvesting areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive prices and extreme transparency. Eevia listed its shares at Stock market in Sweden in June 2021with the short name EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn @EeviaHealth. finance-,c3591242

(c) Decision 2022. All rights reserved., sources Press Releases – English